Mazzo David J 4
4 · LISATA THERAPEUTICS, INC. · Filed Jan 12, 2024
Insider Transaction Report
Form 4
Mazzo David J
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2024-01-11$2.99/sh−1,026$3,068→ 174,766 total
Footnotes (2)
- [F1]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F2]Includes 107,183 unvested restricted stock.